Advertisement

Journal of Neuro-Oncology

, Volume 74, Issue 1, pp 93–95 | Cite as

CHEK2 mutations in primary glioblastomas

  • Satu-Leena Sallinen
  • TarjaI konen
  • Hannu Haapasalo
  • Johanna Schleutker
Letter to the Editor

Keywords

Public Health Primary Glioblastoma CHEK2 Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ino, Y, Silver, JS, Blazejewski, L, Nishikawa, R, Matsutani, M, Deimling, A, Louis, DN 1999Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy gradeJ Neuropathol Exp Neurol58881885PubMedGoogle Scholar
  2. 2.
    Hoang-Xuan, K, Merel, P, Vega, F, Hugot, J-P, Cornu, P, Delattre, J-Y, Poisson, M, Thomas, G, Delattre, O 1995Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomasInt J Cancer60478481PubMedGoogle Scholar
  3. 3.
    Matsuoka, S, Huang, M, Elledge, SJ 1998Linkage of ATM to cell cycle regulation by the Chk2 protein kinaseScience28218931897CrossRefPubMedGoogle Scholar
  4. 4.
    Matsuoka, S, Rotman, G, Ogawa, A, Shiloh, Y, Tamai, K, Elledge, SJ 2000Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitroProc Natl Acad Sci USA971038910394CrossRefPubMedGoogle Scholar
  5. 5.
    Chehab, NH, Malikzay, A, Appel, M, Halazonetis, TD 2000Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53Genes Dev14278288PubMedGoogle Scholar
  6. 6.
    Lee, JS, Collins, KM, Brown, AL, Lee, CH, Chung, JH 2000hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage responseNature404201204CrossRefPubMedGoogle Scholar
  7. 7.
    Falck, J, Mailand, N, Syljuasen, RG, Bartek, J, Lukas, J 2001The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesisNature410842847CrossRefPubMedGoogle Scholar
  8. 8.
    Bell, DW, Varley, JM, Szydlo, TE, Kang, DH, Wahrer, DC, Shannon, KE, Lubratovich, M, Verselis, SJ, Isselbacher, KJ, Fraumeni, JF, Birch, JM, Li, FP, Garber, JE, Haber, DA 1999Heterozygous germ line hCHK2 mutations in Li-fraumeni syndromeScience28625282531CrossRefPubMedGoogle Scholar
  9. 9.
    Lee, SB, Kim, SH, Bell, DW, Wahrer, DC, Schiripo, TA, Jorczak, MM, Sgroi, DC, Garber, JE, Li, FP, Nichols, KE, Varley, JM, Godwin, AK, Shannon, KM, Harlow, E, Haber, DA 2001Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni syndromeCancer Res6180628067PubMedGoogle Scholar
  10. 10.
    Vahteristo, P, Tamminen, A, Karvinen, P, Eerola, H, Eklund, C, Aaltonen, LA, Blomqvist, C, Aittomaki, K, Nevanlinna, H 2001p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predispositionCancer Res6157185722PubMedGoogle Scholar
  11. 11.
    Allinen, M, Huusko, P, Mantyniemi, S, Launonen, V, Winqvist, R 2001Mutation analysis of the CHEK 2 gene in families with hereditary breast cancerBr J Cancer85209212CrossRefPubMedGoogle Scholar
  12. 12.
    Meijers-Heijboer, H, Ouweland, A, Klijn, J, Wasielewski, M, Snoo, A, Oldenburg, R, Hollestelle, A, Houben, M, Crepin, E, Veghel-Plandsoen, M, Elstrodt, F, Duijn, C, Bartels, C, Meijers, C, Schutte, M, McGuffog, L, Thompson, D, Easton, DF, Sodha, N, Seal, S, Barfoot, R, Mangion, J, Chang-Claude, J, Eccels, D, Eeles, R, Evans, DG, Houlston, R, Murday, V, Narod, S, Peretz, T, Peto, J, Phealan, C, Zhang, HX, Szabo, C, Devilee, P, Goldgar, D, Futreal, PA, Nathanson, KL, Weber, BL, Rahman, N, Sratton, MR 2002Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutationsNat Genet315559CrossRefPubMedGoogle Scholar
  13. 13.
    Vahteristo, P, Bartkova, J, Eerola, H, Syrjakoski, K, Ojala, S, Kilpivaara, O, Tamminen, A, Kononen, J, Aittomaki, K, Heikkila, P, Holli, K, Blomqvist, C, Bartek, J, Kallioniemi, OP, Nevanlinna, H 2002A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancerAm J Hum Genet71432438CrossRefPubMedGoogle Scholar
  14. 14.
    Schutte, M, Seal, S, Barfoot, R, Meijers-Heijboer, H, Wasielewski, M, Evans, DG, Eccles, D, Meijers, C, Lohman, F, Klijn, J, Ouweland, A, TheBreastCancer Linkage, Consortium, Futreal, PA, Nathanson, KL, Weber, BL, Easton, DF, Stratton, MR, Rahman, N 2003Variants inCHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibilityAm J Hum Genet7210231028CrossRefPubMedGoogle Scholar
  15. 15.
    Meijers-Heijboer, H, Wijnen, J, Vasen, H, Wasielewski, M, Wagner, A, Hollestelle, A, Elstrodt, F, VanDen Bos, R, De Snoo, A, Tjon, A, Fat, G, Brekelmans, C, Jagmohan, S, Franken, P, Verkuijlen, P, VanDen Ouweland, A, Chapman, P, Tops, C, Moslein, G, Burn, J, Lynch, H, Klijn, J, Fodde, R, Schutte, M 2003The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotypeAm J Hum Genet7213081314CrossRefPubMedGoogle Scholar
  16. 16.
    CHEK2 Breast Cancer Case-Control Consortium2004CHEK2* 1100delC and susceptibility to breast cancer: a collaborative analysis involving 10860 breast cancer cases and 9065 controls from 10 studiesAm J Hum Genet7411751182Google Scholar
  17. 17.
    Kilpivaara, O, Vahteristo, P, Falck, J, Syrjakoski, K, Eerola, H, Easton, D, Bartkova, J, Lukas, J, Heikkila, P, Aittomaki, K, Holli, K, Blomqvist, C, Kallioniemi, OP, Bartek, J, Nevalinna, H 2004CHEK2 variant I157T may be associated with increased breast cancer riskInt J Cancer111543547CrossRefPubMedGoogle Scholar
  18. 18.
    Dong, X, Wang, L, Taniguchi, K, Wang, X, Cunningham, JM, McDonnell, SK, Qian, C, Marks, AF, Slager, SL, Peterson, BJ, Smith, DI, Cheville, JC, Blute, ML, Jacobsen, SJ, Schaid, DJ, Tindall, DJ, Thibodeau, SN, Liu, W 2003Mutations in CHEK2 associated with prostate cancer riskAm J Hum Genet72270280CrossRefPubMedGoogle Scholar
  19. 19.
    Seppala, EH, Ikonen, T, Mononen, N, Autio, V, Rokman, A, Matikainen, MP, Tammela, TLJ, Schleutker, J 2003CHEK2 variants associate with hereditary prostate cancerBr J Cancer8919661970CrossRefPubMedGoogle Scholar
  20. 20.
    Haruki, N, Saito, H, Tatematsu, Y, Konishi, H, Harano, T, Masuda, A, Osada, H, Fujii, Y, Takahashi, T 2000Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancerCancer Res6046894692PubMedGoogle Scholar
  21. 21.
    Miller, CW, Ikezoe, T, Krug, U, Hofmann, WK, Tavor, S, Vegesna, V, Tsukasaki, K, Takeuchi, S, Koeffler, HP 2002Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumorsGenes Chromosomes Cancer331721CrossRefPubMedGoogle Scholar
  22. 22.
    Reddy, A, Yuille, M, Sullivan, A, Repellin, C, Bell, A, Tidy, JA, Evans, DJ, Farrell, PJ, Gusterson, B, Gasco, M, Crook, T 2002Analysis of CHK2 in vulval neoplasiaBr J Cancer86756760CrossRefPubMedGoogle Scholar
  23. 23.
    Ino, Y, Wahrer, DC, Bell, DW, Haber, DA, Louis, DN 2000Mutation analysis of the hCHK2 gene in primary human malignant gliomasNeurogenetics34546PubMedGoogle Scholar
  24. 24.
    Kleihues, PCavenee, WK eds. 2000Astrocytic Tumors. Pathology and Genetics of Tumors of the Nervous SystemIARC PressLyonGoogle Scholar
  25. 25.
    Sallinen, PK, Sallinen, SL, Helen, PT, Rantala, IS, Rautiainen, E, Helin, HJ, Kalimo, H, Haapasalo, HK 2000Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysisComparison of133319331Google Scholar
  26. 26.
    Haapasalo, H, Isola, J, Sallinen, P, Kalimo, H, Helin, H, Ranatala, I 1994Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferationAm J Pathol14213471351Google Scholar
  27. 27.
    Tanner, M, Gancberg, D, Di Leo, A, Larsimont, D, Rouas, G, Piccart, MJ, Isola, J 2000Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samplesAm J Pathol15714671472PubMedGoogle Scholar
  28. 28.
    Wu, X, Webster, SR, Chen, J 2001Characterization of tumor-associated Chk2 mutationsJ Biol Chem27629712974CrossRefPubMedGoogle Scholar
  29. 29.
    Li, J, Williams, BL, Haire, LF, Goldberg, M, Wilker, E, Durocher, D, Yaffe, MB, Jackson, SP, Smerdon, SJ 2002Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2Mol Cell910451054CrossRefPubMedGoogle Scholar
  30. 30.
    Oldenburg, RA, Kroeze-Jansema, K, Kraan, J, Morreau, H, Klijn, JGM, Hoogerbrugge, N, Ligtenberg, MJL, Asperen, CJ, Vasen, HFA, Meijers, C, Meijers-Hejboer, H, Bock, TH, Cornelisse, CJ, Devilee, P 2003The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case familiesCancer Res6381538157PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Satu-Leena Sallinen
    • 1
  • TarjaI konen
    • 2
  • Hannu Haapasalo
    • 3
  • Johanna Schleutker
    • 2
  1. 1.Department of Pediatrics, Genetics ClinicTampere University HospitalTampereFinland
  2. 2.Laboratory of Cancer GeneticInstitutIe of Medical Technology, University of Tampere and Tampere University HospitalTampere
  3. 3.Department of Pathology, Centre for Laboratory MedicineTampere University HospitalTampereFinland

Personalised recommendations